News & Press Releases

Filter
386 found

Pyronaridine/artesunate included in the list of WHO prequalified medicines

15 May 2012
Access & product management

MMV’s Chief Scientific Officer elected to Academy of Medical Sciences

10 May 2012
General

Former MMV ESAC member receives Gairdner Foundation award

17 Apr 2012
General

Ian Bathurst Global Health Travel Awards

02 Apr 2012
General

Sharing the fruits of science to accelerate drug discovery

22 Mar 2012
Open source, R&D

Rewarding innovative ideas

22 Mar 2012
R&D

Double commendation for MMV ESAC member

15 Mar 2012
R&D

Delivery of child-friendly antimalarial hits the 100 million mark

22 Feb 2012
Access & product management

One step closer to blocking the transmission of malaria

21 Feb 2012
R&D

Pyramax® receives positive opinion from the EMA

20 Feb 2012
R&D

Condolence message

10 Feb 2012
General

Yvonne Chaka Chaka becomes first African woman to receive WEF's Crystal Award

26 Jan 2012
General

The year in review

16 Jan 2012
General

Do you have an idea that could revolutionize malaria drug discovery?

12 Jan 2012
R&D

Former MMV ESAC member awarded Queen’s New Year Honour

03 Jan 2012
R&D

MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost

19 Dec 2011
Open source, R&D

U.N. Special Envoy for Malaria, Ray Chambers, and RBM Executive Director, Professor Awa Coll-Seck, awarded “UNCA Citizen of the Year Award”

14 Dec 2011
General

World Malaria Report 2011 highlights fragile progress

13 Dec 2011
General, Partner

New generation of lifesaving medicines and vaccines for the world’s poor now at risk

08 Dec 2011
General

MMV delivers testimony to US congress

05 Dec 2011
General

Marketing authorization for Eurartesim® announced at media roundtable

30 Nov 2011
R&D

New dual-acting antimalarial compounds discovered

17 Nov 2011
R&D

Partnership reaches important milestone

14 Nov 2011
Partner, R&D

Eurartesim® receives stringent regulatory approval from the EMA

10 Nov 2011
General, R&D

Patient screening underway for Pyramax® sub-study in Sotuba, Mali

09 Nov 2011
R&D

SMS for Life wins WSJ Innovation Award 2011

31 Oct 2011
Access & product management

MMV Symposium at EDCTP

20 Oct 2011
General

Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities

11 Oct 2011
General, Partner

Launch of the CAPSS Plus Pilot in Uganda

30 Sep 2011
Access & product management

Chinese scientist wins award for life-saving discovery of artemisinin

23 Sep 2011
General

Molecule moves through preclinical development in record time

02 Sep 2011
Partner, R&D

MMV ESAC member receives accolade for malaria research

22 Aug 2011
Partner, R&D

Pyramax® edges closer to patients

19 Aug 2011
Partner, R&D

The Ian Bathurst Sponsorship Programme

07 Jul 2011
Donors

MMV holds malaria session at The World Conference of Science Journalists

01 Jul 2011
General

MMV loses a dear colleague and friend

28 Jun 2011
General

Artemisinin’s key impurities identified and made available as reference standards

20 Jun 2011
R&D

MMV supports new technique to measure quality of artemisinin

06 Jun 2011
R&D

DHODH awarded MMV’s Project of the Year 2010

01 Jun 2011
General, Partner

Ray Chambers takes over from Baroness Chalker as MMV's Chairman

01 Jun 2011
General

MMV participates in Asia Pacific efforts to eliminate malaria

25 May 2011
R&D

Sanofi-aventis and MMV join forces to develop innovative malaria drugs

05 May 2011
Partner, R&D

Press briefing to mark World Malaria Day

21 Apr 2011
General

Ray Chambers among TIME's Top 100

21 Apr 2011
General

"SMS for Life" rolled-out nationwide in the United Republic of Tanzania

18 Apr 2011
Access & product management

MMV’s CEO delivers strong message at Oslo malaria conference

13 Apr 2011
General

Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria

18 Mar 2011
Partner, R&D

WHO: Low quality drugs continue to afflict Africa

25 Feb 2011
General

G-FINDER 2010: Good news with a twist in the tail for PDPs

18 Feb 2011
Donors, General

Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin

15 Feb 2011
Partner, R&D

Single-dose cure for malaria edges closer to the clinic

08 Feb 2011
Partner, R&D

MMV signs MoU with ALMA at the African Union Summit

03 Feb 2011
Access & product management, Partner

Ground-breaking trial underway to protect pregnant women from malaria

28 Jan 2011
R&D

WHO report calls for urgent action to protect malaria therapies

12 Jan 2011
General

Global plan for artemisinin resistance containment (GPARC)

11 Jan 2011
General

MMV's new CEO comes on board

05 Jan 2011
General

Letter from the CEO

22 Dec 2010
General

World Malaria Report shows scale-up of control activities is paying-off

14 Dec 2010
General

International status granted to three not-for-profit organizations in Switzerland

09 Dec 2010
General

WHO report calls for greater vigilance to allow early detection of artemisinin resistance

18 Nov 2010
General

Pages